Drug class · Endocrine & metabolism
GLP-1 receptor agonists Drug Codes & NDCs
Drugs that activate the glucagon-like peptide-1 (GLP-1) receptor. The class includes injectable and oral products; tirzepatide is also listed here because it acts on both the GLP-1 and GIP receptors.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1340 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1423 |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2002 |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2457 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2460 |
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2471 |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2484 |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2495 |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2506 |
| Zepboundtirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6052 |
| Zepboundtirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6103 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6210 |
| Zepboundtirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6304 |
| Zepboundtirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6523 |
| Zepboundtirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6612 |
| Zepbound KwikPentirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3511 |
| Zepbound KwikPentirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3522 |
| Zepbound KwikPentirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3533 |
| Zepbound KwikPentirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3544 |
| Zepbound KwikPentirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3555 |
| Zepbound KwikPentirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3566 |